The possibility that SCA might reduce I/R damage by activating the Toll-like receptor 4 (TLR4) and Complement component 5a receptor 1 (C5aR1) signaling pathways has also been studied [28]. This evidence concerns the gene C5AR1 and autosomal dominant cerebellar ataxia.